Add to ORKGBackground. The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predominantly based on studies in haemodialysis (HD) patients. However, in clinical practice, this guideline is also applied to peritoneal dialysis (PD) patients. To validate the implementation of this guideline in PD patients, we evaluated the associations between plasma concentrations outside the K/DOQI-targets and the risk of cardiovascular morbidity and mortality in incident PD patients compared with HD patients. Methods. In a large prospective multicentre stud
Background Vascular calcification is common among patients undergoing dialysis and is associated wit...
BACKGROUND: Patients on dialysis may have abnormal serum levels of Ca, P and parathyroid hormone, wi...
Background and objectives Use of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA...
Background. The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Background. The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
BACKGROUND: The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Background and objectivesUnlike hemodialysis (HD), peritoneal dialysis (PD) is a continuous therapy ...
Background. Bone and mineral metabolism is abnormal in most chronic haemodialysis patients and is as...
Background. Dialysis Outcomes and Practice Patterns Study has shown that the proportion of haemodial...
Background and objectives Parathyroid hormone, calcium, and phosphate have been independently associ...
Background and objectives Elevated total serum alkaline phosphatase levels have been associated with...
Background: Mineral metabolism has emerged as an important predictor of morbidity and mortality in d...
Abstract. Total and regional bone mineral densities (BMD) of ten male haemodialysis (HD) patients an...
<b><i>Background:</i></b> Mineral Bone Disorders (MBD) is prevalent in hemodialysis (HD) patients an...
Background. The relationship between blood pressure (BP) and mortality in haemodialysis patients is ...
Background Vascular calcification is common among patients undergoing dialysis and is associated wit...
BACKGROUND: Patients on dialysis may have abnormal serum levels of Ca, P and parathyroid hormone, wi...
Background and objectives Use of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA...
Background. The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Background. The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
BACKGROUND: The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Background and objectivesUnlike hemodialysis (HD), peritoneal dialysis (PD) is a continuous therapy ...
Background. Bone and mineral metabolism is abnormal in most chronic haemodialysis patients and is as...
Background. Dialysis Outcomes and Practice Patterns Study has shown that the proportion of haemodial...
Background and objectives Parathyroid hormone, calcium, and phosphate have been independently associ...
Background and objectives Elevated total serum alkaline phosphatase levels have been associated with...
Background: Mineral metabolism has emerged as an important predictor of morbidity and mortality in d...
Abstract. Total and regional bone mineral densities (BMD) of ten male haemodialysis (HD) patients an...
<b><i>Background:</i></b> Mineral Bone Disorders (MBD) is prevalent in hemodialysis (HD) patients an...
Background. The relationship between blood pressure (BP) and mortality in haemodialysis patients is ...
Background Vascular calcification is common among patients undergoing dialysis and is associated wit...
BACKGROUND: Patients on dialysis may have abnormal serum levels of Ca, P and parathyroid hormone, wi...
Background and objectives Use of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA...